Xagenic logo — Empowering clinicians with rapid, near-patient molecular tes...

Xagenic

Empowering clinicians with rapid, near-patient molecular testing for improved patient care and reduced healthcare costs.

Founded 2010 Series B Total: $63.28M Biotechnology, Health Care +1

General Information

Company Name Xagenic
Founded Year 2010
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series B
Social

Get notified when Xagenic moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Xagenic

Xagenic, based in Toronto, Canada, is a trailblazer in molecular diagnostics, dedicated to developing cutting-edge technology for rapid, near-patient diagnostic testing. Their mission is to equip clinicians with the ability to make timely treatment decisions during the initial patient consultation, ultimately enhancing patient care and reducing healthcare expenses. Xagenic’s innovative approach enables swift, enzyme-free detection of nucleic acids from clinical samples. The company has introduced a user-friendly, fully automated technology platform tailored for widespread diagnostic testing outside traditional clinical laboratories. Their focus is on the development of infectious disease tests capable of rapidly identifying various analytes, providing clinically actionable results in scenarios where fast test turnaround is critical. Founded in 2010, Xagenic operates within the biotechnology, healthcare, and medical devices sectors. Notably, the company received a $15.00M Series B investment on 09 July 2015 from Domain Associates, CTI Life Sciences Fund, The Ontario Capital Growth, and BDC Healthcare Venture, signifying recognized support from reputable investors in the industry.

Taxonomy: molecular diagnostics, rapid testing, point-of-care, infectious disease, clinical samples, decentralized testing, enzyme-free detection, near-patient testing, clinician empowerment

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 4
Investor Investor Investor
•••• ••••
09 Jul 2015
Series B •••••• 3
Investor
•••• ••••
14 Jul 2014
Venture Round •••••• - 10 Dec 2013
Grant •••••• 1
Investor
19 Feb 2013
Series A •••••• 4
Investor Investor
•••• ••••
30 Jan 2012

View All 7 Funding Rounds

Xagenic Alternatives & Competitors

Xagenic vs

Empowering healthcare with innovative near-patient testing and diagnostic solutions since 2009.

Series Unknown
1001-5000 employees
Health Care, Medical Devices
Xagenic vs
Ethos Laboratories
Ethos Laboratories United States

CAP-accredited, CLIA-certified, high-complexity laboratory providing advanced diagnostic intelligenc...

140 employees
Data Analytics, Health Care
Xagenic vs
Vibrant Wellness
Vibrant Wellness United States

We help providers get to the ROOT of patient health concerns through world-class lab testing.

211 employees
Biopharma, Health Care

FAQ About Xagenic

Empowering clinicians with rapid, near-patient molecular testing for improved patient care and reduced healthcare costs.
Xagenic was founded in 2010.
Xagenic operates in the following industries: Biotechnology, Health Care, Medical Devices.
Xagenic has completed 7 funding rounds, raising a total of $63.28M. The latest funding stage is Series B.
Top alternatives and competitors to Xagenic include Accriva Diagnostics, Ethos Laboratories, Vibrant Wellness, heliosDX, Kior Healthcare. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Xagenic and Accriva Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Xagenic and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy